Below are two passages addressing the economic and scientific impacts of pharmaceutical patents.
Passage A
The justification for the pharmaceutical patent framework is clear and compelling: it supplies the indispensable incentive for the immense investments required to bring novel therapeutics to market. Developing a new drug is an arduous process often spanning a decade and costing billions, with the vast majority of candidates failing in clinical trials. Without the temporary exclusivity granted by a patent, generic competitors could immediately replicate successful compounds at a fraction of the cost, completely undermining the original innovator's ability to recoup their initial investment. Consequently, diluting patent protections would inevitably precipitate a drastic decline in the development of life-saving medical treatments.
Passage B
While proponents of the pharmaceutical patent system argue it is necessary to spur research, the reality is that the current framework frequently retards genuine medical advancement. The lure of monopoly pricing encourages companies to focus disproportionately on "evergreening"—making minor, clinically insignificant modifications to existing blockbuster drugs merely to extend their patent life, rather than pursuing entirely novel therapeutics. Furthermore, by locking up foundational discoveries, patents can block cumulative innovation, preventing other researchers from building upon early-stage findings. Transitioning toward alternative models, such as government-funded innovation prizes or expanded public grants, would more effectively stimulate the creation of medically significant treatments without the deadweight loss of patent monopolies.
Based on the arguments presented, match each statement below to the correct description of the authors' respective stances.
- The current pharmaceutical patent regime functions primarily to restrict, rather than promote, the overall advancement of medical science.Passage B's author would agree, but Passage A's author would disagree.
- The exclusive rights granted by patents are an indispensable mechanism for ensuring the continuous development of novel, life-saving therapeutics.Passage A's author would agree, but Passage B's author would disagree.
- The process of discovering, testing, and securing approval for new pharmaceutical compounds requires a massive investment of capital.Both the author of Passage A and the author of Passage B would agree.
- Generic pharmaceutical manufacturers contribute more to the fundamental discovery of new therapeutic compounds than do patent-holding companies.Neither the author of Passage A nor the author of Passage B would agree.